Loading the company…
Loading the company…
In the last ten years FDA made 1 decision for Hartmann (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2024 (1). The latest was on 2024-12-09.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-12-09 | 510(k) | K242758 | Atrauman® Ag |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Hartmann.
In 2025, Hartmann reported engagement with 739 surgeons and other clinicians in the states MedaRep covers, worth $52K in consulting, speaking, meals and travel for its device products, the most in Wisconsin ($9,830 to 24). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Wisconsin ($9,830, 24 engaged), California ($8,709, 6 engaged), Florida ($5,203, 99 engaged), New Jersey ($4,892, 19 engaged), Texas ($4,187, 92 engaged).